プロテインホスファターゼ2 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "プロテインホスファターゼ2" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

2,814^th place

4,178^th place

cell.com

“PP2A: unveiling a reluctant tumor suppressor”. Cell 130 (1): 21–24. (2007). doi:10.1016/j.cell.2007.06.034. PMID 17632053.

doi.org

“Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme”. Nature 445 (7123): 53–7. (January 2007). doi:10.1038/nature05351. PMID 17086192.
“PP2A: unveiling a reluctant tumor suppressor”. Cell 130 (1): 21–24. (2007). doi:10.1016/j.cell.2007.06.034. PMID 17632053.
“The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs”. Cell 96 (1): 99–110. (January 1999). doi:10.1016/S0092-8674(00)80963-0. PMID 9989501.
“Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease”. Neurochemistry International 61 (6): 899–906. (November 2012). doi:10.1016/j.neuint.2012.01.031. PMID 22342821.
“Protein phosphatase 2A dysfunction in Alzheimer's disease”. Frontiers in Molecular Neuroscience 7: 16. (2014). doi:10.3389/fnmol.2014.00016. PMC 3949405. PMID 24653673.
“From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies”. Frontiers in Oncology 5: 21. (2015). doi:10.3389/fonc.2015.00021. PMC 4329809. PMID 25763353.

nih.gov

pubmed.ncbi.nlm.nih.gov

“Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme”. Nature 445 (7123): 53–7. (January 2007). doi:10.1038/nature05351. PMID 17086192.
“PP2A: unveiling a reluctant tumor suppressor”. Cell 130 (1): 21–24. (2007). doi:10.1016/j.cell.2007.06.034. PMID 17632053.
“The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs”. Cell 96 (1): 99–110. (January 1999). doi:10.1016/S0092-8674(00)80963-0. PMID 9989501.
“Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease”. Neurochemistry International 61 (6): 899–906. (November 2012). doi:10.1016/j.neuint.2012.01.031. PMID 22342821.
“Protein phosphatase 2A dysfunction in Alzheimer's disease”. Frontiers in Molecular Neuroscience 7: 16. (2014). doi:10.3389/fnmol.2014.00016. PMC 3949405. PMID 24653673.
“From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies”. Frontiers in Oncology 5: 21. (2015). doi:10.3389/fonc.2015.00021. PMC 4329809. PMID 25763353.

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov